Skip to main content
Clinical Trials/CTRI/2020/03/024268
CTRI/2020/03/024268
Completed
Phase 2

Comparative Efficacy Study of Baladiyapana Basti and Bala Taila Matra Basti in the Management of Katigraha w.s.r. to Lumbar Spondylosis

ational Institute of Ayurveda Jorawar Singh Gate Amber Road Jaipur0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
ational Institute of Ayurveda Jorawar Singh Gate Amber Road Jaipur
Enrollment
60
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 8, 2021
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ational Institute of Ayurveda Jorawar Singh Gate Amber Road Jaipur

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients suffering from classical signs and symptoms of Katigraha w.s.r to Lumbar spondylosis.
  • 2\. Patients between 40 yrs to 60 yrs of age.
  • 3\. Male or female Patient willing and able to participate in the study for 16 days and follow up period of 15 days.
  • 4\. Patients able to provide informed consent.
  • 5\.Grade 2 and Grade 3 in X\-ray findings through Lane Radiographic grading of lumbar disc degeneration on lateral views.

Exclusion Criteria

  • 1\.Patients suffering from any acute diseases, infectious diseases, metabolic diseases, chronic diseases (like rheumatoid Arthritis, DM, Gout, TB, SLE, Ankylosing spondylitis etc) and other disease that may interfere with the course of treatment.
  • 2\. Patients suffering from Stenosis of spinal canal, Myelopathy (MRI optional), Lumbar carcinoma, spinal tumour or malignant tumours in any part of the body.
  • 3\. All type of Lumbar surgery or implanted instrumentation or prosthesis.
  • 4\. Patient having chronicity more than 5 yrs.
  • 5\. Pregnant women and lactating women are excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials